Anubhuti Singh, MBBch, MD, MRCPsych, is affiliated with Devon Partnership NHS Trust in Exeter, United Kingdom, and Saraswati Medical College in Lucknow, India. Singh has published on clinical topics including obsessive-compulsive and related disorders as well as schizophrenia and schizoaffective disorders. Notable articles include studies on olanzapine use in early-onset schizophrenia and serotonin syndrome precipitated by esomeprazole in an adolescent with obsessive-compulsive disorder. Singh’s work appears in Psychiatrist.com, contributing to the understanding of psychiatric pharmacotherapy and adverse drug reactions.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
